Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives

Details for Australian Patent Application No. 2006231836 (hide)

Owner AstraZeneca AB

Inventors Sohn, Daniel; Rein, Tobias; Nordvall, Gunnar; Ray, Colin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006231836

PCT Pub. Number WO2006/107258

Priority 0500767-9 06.04.05 SE

Filing date 3 April 2006

Wipo publication date 12 October 2006

Acceptance publication date 15 July 2010

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/107258 Priority application(s): WO2006/107258

15 July 2010 Application Accepted

  Published as AU-B-2006231836

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006231871-Processing management system and computer-readable recording medium

2006231835-Novel 5,7-disubstituted (1,3)thiazolo(4,5-d)pyrimidin-2(3H)-one derivatives